ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$13.82 +0.73%

+$0.13 today

Market cap
$1.53B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.70M

Average 1.06M

ADRX EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors Peer median
EBITDA Margin for ADRX and competitors
Company Period LTM level YoY 3-year change
MGTXMeiraGTx Holdings plcLTM Mar 2026-120.0% +290.8 pp+619.2 pp
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026-148.9% -100.7 pp-100.7 pp
WVEWave Life Sciences Ltd.LTM Mar 2026-243.2% -144.4 pp+3681.3 pp
PRQRProQR Therapeutics N.V.LTM Mar 2026-319.0% -184.3 pp+1328.5 pp
RNAAtrium Therapeutics, Inc.FY2025-410.9% ——
STOKStoke Therapeutics, Inc.LTM Mar 2026-511.5% -539.6 pp+799.5 pp
PRMEPrime Medicine, Inc.LTM Mar 2026-4732.2% +354.4 pp—
SLNSilence Therapeutics plcLTM Mar 2026-8478.5% —-15524.4 pp
ADRXADARx Pharmaceuticals, Inc.—— ——
BNTCBenitec Biopharma Inc.FY2025— ——
Peer median (excluding ADRX) -365.0%-122.5 pp+709.4 pp

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$13.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.